(-)-Epipodophyllotoxin
CAS No. 4375-07-9
(-)-Epipodophyllotoxin ( (-)-Epipodophyllotoxin )
产品货号. M29434 CAS No. 4375-07-9
(-)-Epipodophyllotoxin (2) is an antiproliferative agent against cancer cells with GI50s of 0.36 and 0.24 μM in HeLa cells and MCF-7 cells, respectively. (-)-Epipodophyllotoxin can inhibit mitotic spindle assembly in vitro.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥786 | 有现货 |
|
10MG | ¥1199 | 有现货 |
|
100MG | 获取报价 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称(-)-Epipodophyllotoxin
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述(-)-Epipodophyllotoxin (2) is an antiproliferative agent against cancer cells with GI50s of 0.36 and 0.24 μM in HeLa cells and MCF-7 cells, respectively. (-)-Epipodophyllotoxin can inhibit mitotic spindle assembly in vitro.
-
产品描述(-)-Epipodophyllotoxin (2) is an antiproliferative agent against cancer cells with GI50s of 0.36 and 0.24 μM in HeLa cells and MCF-7 cells, respectively. (-)-Epipodophyllotoxin can inhibit mitotic spindle assembly in vitro.
-
同义词(-)-Epipodophyllotoxin
-
通路Apoptosis
-
靶点Apoptosis
-
受体Apoptosis
-
研究领域——
-
适应症——
化学信息
-
CAS Number4375-07-9
-
分子量826.8
-
分子式C44H42O16
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCOc1cc([C@@H]([C@H]([C@H](CO2)[C@@H]3O)C2=O)c2c3cc3OCOc3c2)cc(OC)c1OCCOc1cc([C@@H]([C@H]([C@H](CO2)[C@@H]3O)C2=O)c2c3cc3OCOc3c2)cc(OC)c1OC
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
TVB-3166
TVB-3166 induces apoptosis and inhibits in-vivo xenograft tumor growth. TVB-3166 is a reversible and selective fatty acid synthase inhibitor (IC50s: 42 nM and 81 nM for biochemical FASN and cellular palmitate synthesis, respectively).
-
BiP inducer X
BiP inducer X is a selective inducer of immunoglobulin heavy chain binding protein (BiP)/GRP78 and an ER chaperone inducer. BiP inducer X prevents cell death in neurons and retinal cell lines.
-
9-dihydro-13-acetylb...
9-Dihydro-13-acetylbaccatin III is an apoptosis inducer. It shows cytotoxicity against the MCF7 cell line and drug-resistant cell line MCF7-ADR.